Hey THERA executives...any value??Pathology
2023 Feb;55(1):40-51. doi: 10.1016/j.pathol.2022.08.001. Epub 2022 Aug 20.
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer
https://pubmed.ncbi.nlm.nih.gov/36089417/ At least, you can have access to the sortilin antibodies............